Skip to main content

Peer Review reports

From: A phase II study of LFP therapy (5-FU (5-fluorourasil) continuous infusion (CVI) and Low-dose consecutive (Cisplatin) CDDP) in advanced biliary tract carcinoma

Original Submission
2 Oct 2005 Submitted Original manuscript
8 Oct 2005 Author responded Author comments - Kazuma Kobayashi
Resubmission - Version 2
8 Oct 2005 Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
Resubmission - Version 4
Submitted Manuscript version 4
14 Nov 2005 Reviewed Reviewer Report - Vittorio Gebbia
15 Nov 2005 Reviewed Reviewer Report - Nicolas Tsavaris
24 Dec 2005 Author responded Author comments - Kazuma Kobayashi
Resubmission - Version 5
24 Dec 2005 Submitted Manuscript version 5
9 Jan 2006 Author responded Author comments - Kazuma Kobayashi
Resubmission - Version 6
9 Jan 2006 Submitted Manuscript version 6
Resubmission - Version 7
Submitted Manuscript version 7
9 Jan 2006 Author responded Author comments - Kazuma Kobayashi
Resubmission - Version 8
9 Jan 2006 Submitted Manuscript version 8
Resubmission - Version 9
Submitted Manuscript version 9
13 Jan 2006 Author responded Author comments - Kazuma Kobayashi
Resubmission - Version 10
13 Jan 2006 Submitted Manuscript version 10
1 Feb 2006 Reviewed Reviewer Report - Nicolas Tsavaris
12 Mar 2006 Author responded Author comments - Kazuma Kobayashi
Resubmission - Version 11
12 Mar 2006 Submitted Manuscript version 11
Resubmission - Version 12
Submitted Manuscript version 12
23 Mar 2006 Reviewed Reviewer Report - Nicolas Tsavaris
8 Apr 2006 Author responded Author comments - Kazuma Kobayashi
Resubmission - Version 13
8 Apr 2006 Submitted Manuscript version 13
22 Apr 2006 Author responded Author comments - Kazuma Kobayashi
Resubmission - Version 14
22 Apr 2006 Submitted Manuscript version 14
4 May 2006 Author responded Author comments - Kazuma Kobayashi
Resubmission - Version 15
4 May 2006 Submitted Manuscript version 15
Publishing
6 May 2006 Editorially accepted
6 May 2006 Article published 10.1186/1471-2407-6-121

You can find further information about peer review here.

Back to article page